Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-032291)

Filing Details

Accession Number:: 0001209191-20-032291
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-05-27 16:14:20
Reporting Period:: 2020-05-26

Accepted Time:: 2020-05-27 16:14:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1419600	Flexion Therapeutics Inc	FLXN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1487937	Mark Stejbach	C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-05-26	2,051	$9.75	2,051	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,580	Indirect	By The Mark P. Stejbach Revocable Trust UA 07-08-2016

Footnotes

The shares were purchased in connection with the Issuer's public offering.